|
|
 |
|
Viewing report
|
|
|
|
Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond
Spectra Intelligence , Jan 2006, Pages: 580
Objectives of the Report
The objectives of this report are to provide an in-depth analysis of the global antiageing and life enhancement therapeutic market. Included in this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The report also aims to expand knowledge of the therapeutic areas and to highlight the role of antiageing medicines and lifestyle drugs in an increasingly ageing world population. It is hoped that the reader will benefit from market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to stimulate growth and create new market opportunities.
REPORT HIGHLIGHTS AND KEY FINDINGS
- Data-intensive multipart tome on the state of the US$36bn antiageing and life enhancement drug market
- In-depth market research and analysis of over 15 market sectors and subsectors
- Comprehensive review of epidemiological, aetiological and therapeutic data for over 40 disorders
- Sales estimates (US$) to 2012 for over 90 key products
- Therapy forecasting for 10 specialty areas (US$)
- Strategic insights for life-cycle optimization and product development
- Evaluation of leading products and major competitors
- Identified emerging growth markets with high-revenue yielding prospects
- Recognized market drivers and inhibitors in the specialty pharma sector
- Trend analysis of industry events and activities over the past 2 years
- Detailed R&D themes and clusters by therapy area
- Data generation on sector and market values between 2004-2012 and predictions to 2020 (US$)
REASONS TO PURCHASE THIS REPORT
- Qualitative assessment of current disorder characteristics, definitions, including aetiological and epidemiological data
- Comprehensive update on antiageing and life enhancement drugs sector
- In-depth analysis and discussion on the pathophysiology and prevalence of the main ageing and lifestyle disorders, including alopecia, cutaneous ageing, pigmentations conditions, obesity, depressive illnesses, addictions, sleep disorders, cognitive and memory impairments, contraception, infertility, and sexual disorders
- Provides unrivalled insight into the development of antiageing and life enhancement drugs and emerging market opportunities
- Market value predictions by therapy area and for individual marketed products to 2012
- Quantitative analysis of marketed drugs and impact of new close-to-market candidates and pipeline products
- Insight into potential blockbusters and super-blockbusters of the future
- Illustrates the importance and need for antiageing and lifestyle medicines over the next 20 years
- Provides extensive coverage of R&D pipelines of key players in the sector
- Shows proprietary market modelling for prospect analysis across 15 main therapy areas.
WHAT CAN I LEARN FROM THIS REPORT?
- How are antiageing and lifestyle conditions defined and characterized?
- What are the main areas of antiageing and lifestyle drug development?
- What are the therapeutic benefits of antiageing and lifestyle drugs?
- What criteria are involved in creating blockbuster antiageing and life enhancement drugs?
- What is the impact of global ageing in lifestyle drug development?
- What are the prevalence rates of ageing conditions and lifestyle disorders globally?
- What factors are shaping the future of antiageing and lifestyle drug drug development?
- What are the current market values for antiageing and life enhancement drugs and what will be the market value of this sector by 2012?
- What are the emerging market opportunities for antiageing drugs?
- What are the emerging market opportunities for life enhancement drugs?
- Which therapeutic areas are identified for high-value growth?
- Who are the main players in the antiageing and life enhancement domain?
- Which companies are developing antiageing and life enhancement drugs?
- Which antiageing and lifestyle drug development therapeutic areas are research intensive and which are not?
- Which therapy areas are saturated and which represent niche market opportunities?
- What is the future outlook for marketed antiageing and lifestyle drugs and for those in development?
- What is the prediction for the global markets by 2020?
- What are the top prospects in the development pipeline for antiageing and life enhancement therapy sectors?
Plus Many Other Insights, Observations, Assumptions, and Predictions to be Garnered…
Research Methodology
The contents of this report are derived from in-depth research-based surveys of the industry; communication with senior corporate executives; and proprietary analytical assessment tools. Source material also comprises the following:
- Company information
- Personal communication
- Trade press articles
- News releases
- Internet-based research
- Library research
- Scientific periodicals
- Product information
- Market analyst data
- Public information datasets
- Conference proceeding
- Medical/pharma associations
Customers who bought this item also bought
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry
World Market for Addiction Disorders, 2009–2016, The Future Therapies for Substance Dependence and Impulse Control
The Global Market For Sleep-Wake Disorders, 2005-2012: Trends, Opportunities, and Insights in A High-Value Cns Therapy Area
Insomnia or Sleep Disorders Therapy Area Pipeline Report
Erectile Dysfunction Therapy Area Pipeline Report
Sleep Disorders in the United States 2008
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
Stakeholder Opinions: Female Sexual Dysfunction - Results From Datamonitors 2005 Physician Survey
Stakeholder Insight: Infertility - Undifferentiated Drugs Force need to Strengthen Prescriber and Payer Relationship
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report
The Global Image Dermatology Drug Market, 2005-2012: High-Growth Opportunities in Aesthetic Medicine
|
|
|
|
